Source: Medical Buyer

PQ Bypass: Endologix acquires PQ Bypass

Endologix LLC, a firm specializing in vascular disease treatments, has completed the acquisition of PQ Bypass Inc., a privately held medical technology company pioneering a technology that addresses an unmet need for new treatments for severe peripheral arterial disease . PQ Bypass' proprietary Detour platform for percutaneous femoral-popliteal bypass was designated by the U.S. Food [...] The post Endologix acquires PQ Bypass appeared first on Medical Buyer.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Richard Ferrari's photo - Chairman & CEO of PQ Bypass

Chairman & CEO

Richard Ferrari

CEO Approval Rating

78/100

Read more